A nomogram to estimate the HbA1c response to different DPP-4 inhibitors in type 2 diabetes: a systematic review and meta-analysis of 98 trials with 24 163 patients-Reference-Cited by-同舟云学术

A nomogram to estimate the HbA1c response to different DPP-4 inhibitors in type 2 diabetes: a systematic review and meta-analysis of 98 trials with 24 163 patients

Published:2015-02-16 Issue:2 Volume:5 Page:e005892-e005892
ISSN:2044-6055
Container-title:BMJ Open
language:en
Short-container-title:BMJ Open

Author:

Esposito K.,Chiodini P.,Maiorino M. I.,Capuano A.,Cozzolino D.,Petrizzo M.,Bellastella G.,Giugliano D.

Publisher

BMJ

Subject

General Medicine

Reference32 articles.

1. American diabetes association; European association for the study of diabetes. Management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement from the American diabetes association and the European association for the study of diabetes;Nathan;Diabetes Care,2009

2. Comprehensive diabetes management algorithm;American Association of Clinical Endocrinologists;Endocr Pract,2013

3. Standards of medical care in diabetes—2014;American Diabetes Association Position Statement;Diabetes Care,2014

4. Centre for Clinical Practice at NICE. Type 2 diabetes: newer agents. NICE short clinical guideline 87 Issue date May 2009.

5. When metformin fails in type 2 diabetes mellitus;Esposito;Arch Intern Med,2011

Cited by 68 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sex differences in type 2 diabetes;Diabetologia;2023-03-10

2. Efficacy and safety of sitagliptin treatment in older adults with moderately controlled type 2 diabetes: the STREAM study;Scientific Reports;2023-01-04

3. Learn from failures and stay hopeful to GPR40, a GPCR target with robust efficacy, for therapy of metabolic disorders;Frontiers in Pharmacology;2022-10-25

4. Type 2 diabetics followed up by family physicians: Treatment sequences and changes over time in weight and glycated hemoglobin;Primary Care Diabetes;2022-10

5. Effectiveness and safety of teneligliptin added to patients with type 2 diabetes inadequately controlled by oral triple combination therapy: A multicentre, randomized, double‐blind, and placebo‐controlled study;Diabetes, Obesity and Metabolism;2022-03-17